Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination (MVA(TB)029)

This study has been completed.
Sponsor:
Collaborators:
Medical Research Council
Wellcome Trust
Department for International Development, United Kingdom
University of Oxford
University of Stellenbosch
Oxford-Emergent Tuberculosis Consortium
Information provided by (Responsible Party):
Mark Hatherill, University of Cape Town
ClinicalTrials.gov Identifier:
NCT01650389
First received: July 23, 2012
Last updated: September 29, 2015
Last verified: September 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2015
  Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)